{
    "SPADE_UN_26842": {
        "Sequence Information": {
            "Peptide Name": "Oligo10",
            "Sequence": "FAKALKALLKALKAL",
            "Sequence Length": 15,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections.",
                    "Pubmed ID": "36978418",
                    "Reference": "J Antibiot (Tokyo). 2023;12:551",
                    "Author": "Ramata-Stunda A, Boroduskis M, Kaktina E, Patetko L, Kalnenieks U, Lasa Z, Rubina M, Strazdina I, Kalnins G, Rutkis R",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/36978418"
                }
            ],
            "Mass": 1599.06,
            "PI": 10.48,
            "Net Charge": 4,
            "Hydrophobicity": 1.01,
            "Frequent Amino Acids": "ALK",
            "Absent Amino Acids": "CDEGHIMNOPQRSTUVWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 4,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26842",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11038",
                    "Similarity": 1.0,
                    "Sequence": "LLSNVAGLLKQFAK"
                },
                {
                    "SPADE_ID": "SPADE_N_11039",
                    "Similarity": 1.0,
                    "Sequence": "LLRRVAGLLKQFAK"
                },
                {
                    "SPADE_ID": "SPADE_UN_01169",
                    "Similarity": 1.0,
                    "Sequence": "KFAKKFAKKFAKKFAK"
                }
            ],
            "Hemolytic Activity": "Mouse fibroblasts BALB/3T3:IC50=218.21 µg/ml,Human dermal fibroblasts:IC50=241.54 µg/ml,Human erythrocytes:18% Hemolysis=32 µg/ml",
            "Target Organism": "Escherichia coli(MIC=16.0µg/ml),Pseudomonas aeruginosa(MIC=63.0µg/ml),Klebsiella pneumoniae(MIC=63.0µg/ml),Enterococcus faecium(MIC=16.0µg/ml),Staphylococcus aureus(MIC=4.0µg/ml),Cutibacterium acnes(MIC=2.0µg/ml)"
        }
    }
}